Understanding vision problems in premature infants
Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study
This study is looking to gather important information about retinopathy of prematurity (ROP) in premature babies, using advanced technology to understand how both medical and social factors can affect their vision and overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10840906 on NIH RePORTER |
What this research studies
This research aims to plan a large-scale study that will collect detailed social, clinical, and biomarker data to better understand retinopathy of prematurity (ROP), a condition that can lead to blindness in premature infants. The study will involve multiple centers and will utilize advanced techniques such as retina imaging and artificial intelligence to analyze the data. By focusing on both the medical and social factors affecting these infants, the research seeks to identify the causes and consequences of visual impairments in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are extremely preterm infants born at less than 28 weeks of gestation.
Not a fit: Patients who are not premature or who do not have retinopathy of prematurity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for vision problems in premature infants.
How similar studies have performed: Previous research has shown success in using multicenter observational studies and advanced imaging techniques to study similar conditions, indicating a promising approach.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Dammann, Olaf — Tufts University Boston
- Study coordinator: Dammann, Olaf
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.